Academic literature on the topic 'In vivo'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'In vivo.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "In vivo"
Lenchenko, Ekaterina M., Dmitry A. Blumenkrants, Vladislav V. Ponomarev, Inna B. Pavlova, and Galina S. Tolmacheva. "METHODOLOGICAL ASPECTS OF RESEARCH OF COMPOSITION OF BIOFILMS in vitro, ex vivo, in vivo." Problems of veterinary sanitation, hygiene and ecology 1, no. 41 (2022): 73–82. http://dx.doi.org/10.36871/vet.san.hyg.ecol.202201009.
Full textShishatskaya, Ekaterina I. "Biodegradation of PHA in vivo." Journal of Siberian Federal University. Biology 9, no. 1 (March 2016): 21–32. http://dx.doi.org/10.17516/1997-1389-2016-9-1-21-32.
Full textvan Luijk, S. J., F. Scheele, and C. P. M. van der Vleuten. "Toetsing in vivo bij ‘In VIVO’." Tijdschrift voor Medisch Onderwijs 27, no. 6 (December 2008): 279–87. http://dx.doi.org/10.1007/bf03078290.
Full textMitterhauser, Markus, Stefan Toegel, Wolfgang Wadsak, Rupert R. Lanzenberger, Leonhard-Key Mien, Claudia Kuntner, Thomas Wanek, et al. "Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP." Nuclear Medicine and Biology 34, no. 4 (May 2007): 391–97. http://dx.doi.org/10.1016/j.nucmedbio.2007.03.002.
Full textHuven, Paula. "Reativar o vivo, atravessar a floresta." MODOS: Revista de História da Arte 7, no. 1 (February 13, 2023): 344–68. http://dx.doi.org/10.20396/modos.v7i1.8670588.
Full textIlinskaya, O. N., and H. Fret. "Genotoxical effects of ribonuclease in vivo." Biopolymers and Cell 16, no. 4 (July 20, 2000): 270–74. http://dx.doi.org/10.7124/bc.000570.
Full textGurova, S. V., T. M. Kecheryukova, A. S. Goncharova, E. N. Kolesnikov, M. A. Kozhushko, and M. Z. Tatimov. "MODELS OF LIVER CANCER IN VIVO." Современные проблемы науки и образования (Modern Problems of Science and Education), no. 4 2023 (2023): 14. http://dx.doi.org/10.17513/spno.32707.
Full textChen, Gong. "In vivo confusion over in vivo conversion." Molecular Therapy 29, no. 11 (November 2021): 3097–98. http://dx.doi.org/10.1016/j.ymthe.2021.10.017.
Full textBorgström, L. "In vitro, ex vivo, in vivo veritas." Allergy 54, s49 (March 1999): 88–92. http://dx.doi.org/10.1111/j.1398-9995.1999.tb04394.x.
Full textTümmler, Burkhard. "In-vivo and ex-vivo functional assessment." Journal of Cystic Fibrosis 3 (August 2004): 149–50. http://dx.doi.org/10.1016/j.jcf.2004.05.031.
Full textDissertations / Theses on the topic "In vivo"
Gerez, Juliana Rubira. "Fusariotoxinas em suínos : efeitos tóxicos in vivo e ex vivo." Universidade Estadual de Londrina. Centro de Ciências Agrárias. Programa de Pós-Graduação em Ciência Animal, 2014. http://www.bibliotecadigital.uel.br/document/?code=vtls000194847.
Full textIn order to evaluate the systemic effects of food contamination by mycotoxins, emphasizing morphological and immunohistochemical aspects, two experiments were conducted. In the first experiment, 20 5-week-old piglets were randomly assigned to four groups. The animals received for 28 days the following treatments: control diet, a diet contaminated with deoxynivalenol DON (1.5 mg/kg), a diet contaminated with DON (2.0 mg/kg) + nivalenol (NIV) (1.3 mg/kg) + zearalenone (ZEA) (1.5 mg/kg) or a diet contaminated with DON (3.0 mg/kg) + NIV (1.3 mg/kg) + ZEA (1.5 mg/kg). The mono-contaminated diet showed no difference in weight gain, however the animals fed the multicontaminated diets presented a significant decrease in final weight gain. The chronic ingestion of these contaminated diets induced histological changes in the intestine as show by atrophy and fusion of villi, decreased villi height and crypth depth, and reduced number of goblet cells and lymphocytes. The liver, mesenteric lymph nodes and spleen of animals exposed to contaminanted diets showed a significant increase of lesions. A significant increase in caspase-3 expression in lymph nodes and spleen was observed in animals receiving the contaminated diets. In the second experiment, 12 4 to 5-week-old piglets were euthanized to obtain jejunal explants, which were exposed to 5 treatments for 4 hours, under constant stiring at 37ºC and 5% CO2 humidified atmosphere. In the control treatment were used the Williams medium E without or with the diluent DMSO to 0.1%. In the other treatments the explants were exposed to DON, NIV (1, 3, 10 µM) and fusarenone X (FX) (0.3, 1 and 3 µM). After incubation, the tissue samples were histologically processed and analyzed using histological score. The analyse of samples non-incubated and incubated with culture medium in the absence or presence of DMSO showed no significant different of histopathological score. The main lesions observed in the explants exposed to mycotoxins were villi atrophy, cuboidal and squamous epithelial cells, areas of oedema in the lamina propria and apical denudation with loss of enterocytes. The individual treatment with DON, NIV and FX resulted in a significant decrease of the histopathologic score from doses of 3µM, 1µM and 0.3 µM, respectively. In conclusion, the data obtained provide a better understanding of the possible effects of Fusarium toxins, alone or in combination on the morphology of the intestine and lymphoid organs, which would may predispose animals to secondary infections.
Ryan, de Medeiros Anna Katharina [Verfasser], and Katja Elisabeth [Akademischer Betreuer] Odening. "In vivo und ex vivo Charakterisierung des arrhythmogenen Phänotyps transgener SQT1 Kaninchen = In vivo and ex vivo characterization of the arrhythmic phenotype of transgenic SQT1 rabbits." Freiburg : Universität, 2018. http://d-nb.info/1150643420/34.
Full textMüller, Robert [Verfasser]. "Radikalbildung in vivo /ex vivo nach Bestrahlung verschiedener Wellenlängen / Robert Müller." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2021. http://d-nb.info/1228859744/34.
Full textBarbosa, De Brito Marina de Lurdes. "Cellular integration of the dopamine signal ex vivo and in vivo." Paris 6, 2011. http://www.theses.fr/2011PA066695.
Full textShim, Martin George Nielson. "Analysis of biological tissue with ex vivo and in vivo Raman spectroscopy." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape16/PQDD_0001/MQ28780.pdf.
Full textSteffen, Thomas. "Three-dimensional spine biomechanics, a combined in-vivo and ex-vivo approach." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape11/PQDD_0023/NQ50301.pdf.
Full textSteffen, Thomas 1958. "Three-dimensional spine biomechanics : a combined in-vivo and ex-vivo approach." Thesis, McGill University, 1998. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=35502.
Full textIngram, Rachel. "Mechanisms and treatments for neuropathic pain : in vivo and ex vivo investigations." Thesis, King's College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.440475.
Full textGómez, Segura Lídia. "Estudi farmacològic del Carprofen ex vivo i in vivo en l’espècie porcina." Doctoral thesis, Universitat Autònoma de Barcelona, 2021. http://hdl.handle.net/10803/673755.
Full textEl Carprofè utiliza como agente antiinflamatorio, analgésico y antipirético. Pertenece a la familia de medicamentos antiinflamatorios no esteroideos. Se utiliza en medicina veterinaria en numerosas especies, aún así está muy poco estudiado su uso en la especie porcina. Por otra parte, algunos efectos indeseables se asocian a su administración sistémica. Las rutas locales alternativas son especialmente útiles para facilitar su administración en animales. La hipótesis de este trabajo es encontrar nuevas formas de dosificación del Carprofè por diversas vías en la especie porcina. Por ello, nos planteamos varios objetivos: hemos querido conocer la capacidad de permeación del Carprofè a través de estudios ex vivo vehiculizado en nanopartículas o en solución en mucosas y tejidos oculares para lograr conocer su posible eficacia, tolerancia y seguridad por estas vías y ofrecer alternativas terapéuticas. Por otra parte, queremos conocer el comportamiento farmacocinético del Carprofè en la especie porcina y así, poder evaluar todos los parámetros para la vía intravenosa e intramuscular. Finalmente, nos proponemos validar diferentes métodos de análisis para dar fiabilidad a los resultados obtenidos. En esta tesis hemos realizado tres trabajos para dar respuesta a los Notro objetivos: 1. El objetivo principal del primer artículo es validar la idoneidad de los experimentos de permeación ex vivo de Carprofè en membranas mucosas porcinas (bucales, sublinguales y vaginales) y tejidos oftálmicos (córnea, esclera y conjuntiva) destinados a ser representativos de condiciones in vivo . Los resultados se pueden consultar en el siguiente artículo publicado: - Gómez-Segura, L .; Parra, A .; Calpena, A.C .; Gimeno, Á .; Boix-Montañes, A. Carprofen Permeation Test through Porcine Ex Vivo Mucous Membranas and Ophthalmic Tissues for Tolerability Assessments: Validation and Histological Study. Veterinary Sciences. 2020, 7, 152. 2. El objetivo principal del segundo trabajo es la investigación de la permeación ex vivo de Carprofè mediante Cellu de Franz a través de diferentes tipos de membranas mucosas porcinas y tejidos oftálmicos previamente mencionados para comparar la formulación de nanopartículas de Carprofè y Carprofè en solución. Además, se realizaron estudios in vivo para verificar que las formulaciones no afectaban la estructura celular y establecer la cantidad retenida a los tejidos. Los resultados se pueden consultar en el siguiente artículo publicado: - Gómez-Segura, L .; Parra, A .; Calpena-Campmany, A.C .; Gimeno, Á .; Gómez de Aranda, Y .; Boix-Montañes, A. Ex Vivo Permeation of Carprofen Vehiculated by PLGA nanoparticles through Porcine Mucous Membranas and Ophthalmic Tissues. Nanomateriales. 2020, 10, 355. 3. El tercer trabajo se base en el objetivo de proporcionar un estudio por primera vez de la farmacocinética del Carprofè en cerdos Yorkshire-Landrace. Además, un nuevo método de análisis mediante cromatografía de líquidos por espectrometría de masas nos ha permitido calcular las concentraciones plasmáticas, evaluar los parámetros farmacocinéticos y la biodisponibilidad (también hemos validado este nuevo método analítico). Los resultados se podrán consultar próximamente en el siguiente artículo pendiente de ser publicado: - Gómez-Segura, L .; Parra, A .; Gimeno, Á; Calpena-Campmany, A.C .; Bellido, D .; Soriano-Ruiz J.L .; Boix-Montañes A. Application of liquid chromatography / mass spectrometry for Bioanalysis of Carprofen in swine: pharmacokinetics and Bioavailability. Pendiente de enviar. Como conclusiones finales se ha demostrado la idoneidad de este test para cuantificar la distribución de Carprofè con una buena tolerabilidad histológica en los tejidos porcinos estudiados. Sin embargo, se concluyó que las nanopartículas de Carprofè pueden ser una herramienta útil para el tratamiento tópico de la inflamación local en medicina veterinaria y humana. Para finalizar, se ha descrito y validado un nuevo método para caracterizar la farmacocinética del Carprofè en cerdos y proponer un régimen de dosificación en esta especie.
Carprofen is used as an anti-inflammatory, analgesic and antipyretic agent. It belongs to the family of non-steroidal anti-inflammatory drugs. It is used in veterinary medicine in many species, although its use in the porcine species is very little studied. On the other hand, some side effects are associated with its systemic administration. Alternative local routes are especially useful for ease of administration in animals. The hypothesis of this work is to find new ways of dosing Carprofen in various ways in porcine species. Therefore, we set ourselves several objectives: we wanted to know the permeation capacity of Carprofen through ex vivo studies carried in nanoparticles or in solution in mucous membranes and eye tissues to get to know its possible efficacy, tolerance and safety by these routes offer therapeutic alternatives. On the other hand, we want to know the pharmacokinetic behavior of Carprofen in the porcine species and thus be able to evaluate all the parameters intravenously and intramuscularly. Finally, we propose to validate different methods of analysis to give reliability to the results obtained. In this thesis we have carried out three works to respond to our objectives: 1. The main objective of the first article is to validate the suitability of ex vivo permeation experiments of Carprofen in porcine mucous membranes (buccal, sublingual and vaginal) and ophthalmic tissues (cornea, sclera and conjunctiva) intended to be representative of in vivo conditions. . The results can be consulted in the following published article: - Gómez-Segura, L .; Parra, A .; Calpena, A.C .; Gimeno, Á .; Boix-Montañes, A. Carprofen Permeation Test through Porcine Ex Vivo Mucous Membranes and Ophthalmic Tissues for Tolerability Assessments: Validation and Histological Study. Veterinary Sciences. 2020, 7, 152. 2. The main objective of the second work is the investigation of the ex vivo permeation of Carprofen by Franz cells through different types of porcine mucous membranes and ophthalmic tissues previously mentioned to compare the formulation of nanoparticles of Carprofen and Carprofen in solution. In addition, in vivo studies were performed to verify that the formulations did not affect cell structure and to establish the amount retained in tissues. The results can be consulted in the following published article: - Gómez-Segura, L .; Parra, A .; Calpena-Campmany, A.C .; Gimeno, Á .; Gómez de Aranda, I .; Boix-Montañes, A. Ex Vivo Permeation of Carprofen Vehiculated by PLGA Nanoparticles through Porcine Mucous Membranes and Ophthalmic Tissues. Nanomaterials. 2020, 10, 355. 3. The third work is based on the aim of providing a first study of the pharmacokinetics of Carprofen in Yorkshire-Landrace pigs. In addition, a new method of analysis by liquid chromatography by mass spectrometry has allowed us to calculate plasma concentrations, evaluate pharmacokinetic parameters and bioavailability (we have also validated this new analytical method). The results will be available soon in the following article pending publication: - Gómez-Segura, L .; Parra, A .; Gimeno, Á; Calpena-Campmany, A.C .; Bellido, D .; Soriano-Ruiz J.L .; Boix-Montañes A. Application of liquid chromatography / mass spectrometry for bioanalysis of Carprofen in swine: pharmacokinetics and bioavailability. Pending submission. Final conclusions have been shown to be suitable for this test to quantify the distribution of Carprofen with good histological tolerability in swines tissues studied. However, it was concluded that Carprofen nanoparticles may be a useful tool for the topical treatment of local inflammation in veterinary and human medicine. Finally, a new method has been described and validated to characterize the pharmacokinetics of Carprofen in swines and to propose a dosing regimen in this species.
Universitat Autònoma de Barcelona. Programa de Doctorat en Medicina i Sanitat Animals
Blenkiron, Marc. "Reprogrammable in vivo architecture." Thesis, University of Edinburgh, 2006. http://hdl.handle.net/1842/29220.
Full textBooks on the topic "In vivo"
Vive tu vida al rojo vivo. New York: Atria Books, 2009.
Find full textBörner, Katy, Michael Conlon, Jon Corson-Rikert, and Ying Ding. VIVO. Cham: Springer International Publishing, 2012. http://dx.doi.org/10.1007/978-3-031-79435-3.
Full textPeregrín, Josefina Martos. Mortalmente vivo. Granada: Ediciones Dauro, 2014.
Find full textRadius, Emilio. Verdi vivo. Milano: Baldini & Castoldi, 2001.
Find full text1926-, Ronfani Ugo, ed. Goldoni vivo. Roma: Presidenza del consiglio dei ministri, Dipartimento per l'informazione e l'editoria, 1994.
Find full textHeredia, Eugenio Moreno. Presente vivo. Cuenca, Ecuador: Departamento de Difusión Cultural de la Universidad de Cuenca, 1989.
Find full textBarrios, Jesús Enrique. Mientras vivo. Barquisimeto, Lara, Venezuela: Ediciones de Rectorado de la Universidad Centroccidental "Lisandro Alvarado", 2006.
Find full textLavoro vivo. Roma: Alegre, 2012.
Find full textIn vivo. Beograd: Narodna knjiga-Alfa, 2007.
Find full textArnoldo, Mosca Mondadori, ed. Eternamente vivo. 2nd ed. [Milan, Italy]: Frassinelli, 2010.
Find full textBook chapters on the topic "In vivo"
Tomich, Liz, and Alex Viggio. "Case Study: University of Colorado Boulder." In VIVO, 53–64. Cham: Springer International Publishing, 2012. http://dx.doi.org/10.1007/978-3-031-79435-3_4.
Full textAlbert, Paul J., Curtis Cole, Dan Dickinson, John Ruffing, Markus Bronniman, Eliza Chan, and Kenneth Lee. "Case Study: Weill Cornell Medical College." In VIVO, 65–83. Cham: Springer International Publishing, 2012. http://dx.doi.org/10.1007/978-3-031-79435-3_5.
Full textConlon, Michael. "Scholarly Networking Needs and Desires." In VIVO, 1–13. Cham: Springer International Publishing, 2012. http://dx.doi.org/10.1007/978-3-031-79435-3_1.
Full textBarnes, Chris, Stephen Williams, Vincent Sposato, Nicholas Skaggs, Narayan Raum, Jon Corson-Rikert, Brian Caruso, and Jim Blake. "Extending VIVO." In VIVO, 85–103. Cham: Springer International Publishing, 2012. http://dx.doi.org/10.1007/978-3-031-79435-3_6.
Full textDavis, Valrie, Kristi L. Holmes, Brian J. Lowe, Leslie McIntosh, Liz Tomich, and Alex Viggio. "Implementing VIVO and Filling It with Life." In VIVO, 35–52. Cham: Springer International Publishing, 2012. http://dx.doi.org/10.1007/978-3-031-79435-3_3.
Full textKrafft, Dean B., Katy Börner, Jon Corson-Rikert, and Kristi L. Holmes. "The Future of VIVO: Growing the Community." In VIVO, 129–41. Cham: Springer International Publishing, 2012. http://dx.doi.org/10.1007/978-3-031-79435-3_8.
Full textHeppner, John B., D. G. Boucias, J. C. Pendland, Andrei Sourakov, Timothy Ebert, Roger Downer, Kun Yan Zhu, et al. "In Vivo." In Encyclopedia of Entomology, 2044. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6359-6_1582.
Full textAdler, I.-D. "Mutagenitätstestsin vivo." In Toxikologie, 343–56. Weinheim, FRG: Wiley-VCH Verlag GmbH & Co. KGaA, 2005. http://dx.doi.org/10.1002/3527604820.ch21.
Full textCarroll, Marilyn E., Peter A. Santi, Joseph Zohar, Thomas R. E. Barnes, Peter Verheart, Per Svenningsson, Per E. Andrén, et al. "In vivo." In Encyclopedia of Psychopharmacology, 628. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_928.
Full textBatley-Matias, Pili, and Brian Hill. "Vivo en …" In Breakthrough Video Spanish, 64–69. London: Macmillan Education UK, 1989. http://dx.doi.org/10.1007/978-1-349-80683-6_14.
Full textConference papers on the topic "In vivo"
Han, Bo, Yu Liu, and Feng Qian. "ViVo." In MobiCom '20: The 26th Annual International Conference on Mobile Computing and Networking. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3372224.3380888.
Full textZhu, Yeshuang, Yuntao Wang, Chun Yu, Shaoyun Shi, Yankai Zhang, Shuang He, Peijun Zhao, Xiaojuan Ma, and Yuanchun Shi. "ViVo." In CHI '17: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2017. http://dx.doi.org/10.1145/3025453.3025779.
Full textOraevsky, Alexander, Elena V. Savateeva, Alexander A. Karabutov, Brent Bell, Richard Johnigan, Jay P. Pasricha, and Massoud Motamedi. "Application of the confocal opto-acoustic tomography in detection of squamous epithelial carcinoma at early stages." In In Vivo optical Imaging at the NIH. Washington, D.C.: Optica Publishing Group, 1999. http://dx.doi.org/10.1364/ivoi.1999.dis153.
Full textGeorge, John S., David M. Rector, Cheng Ho, Kevin Albright, Clayton Smith, and Andreas H. Hielscher. "Time Resolved Photon Migration Tomography with a Novel Remote Ultra Low Light Imager (RULLI)." In In Vivo optical Imaging at the NIH. Washington, D.C.: Optica Publishing Group, 1999. http://dx.doi.org/10.1364/ivoi.1999.dis177.
Full textLiu, Hanli, Cole A. Giller, and Maureen Johns. "Brain Structural Mapping during Stereotactic Surgery for Movement Disorders Using Optical Reflectance Spectroscopy." In In Vivo optical Imaging at the NIH. Washington, D.C.: Optica Publishing Group, 1999. http://dx.doi.org/10.1364/ivoi.1999.dis100.
Full textPogue, Brian W., Troy O. McBride, Steven P. Poplack, Ulf L. Osterberg, and Keith D. Paulsen. "Imaging hemoglobin concentration and oxygen saturation in the female breast with near-infrared diffusion tomography." In In Vivo optical Imaging at the NIH. Washington, D.C.: Optica Publishing Group, 1999. http://dx.doi.org/10.1364/ivoi.1999.dis124.
Full textBoppart, Stephen A., Wolfgang Drexler, Uwe Morgner, Franz X. Kärtner, and James G. Fujimoto. "Ultrahigh Resolution and Spectroscopic OCT Imaging of Cellular Morphology and Function." In In Vivo optical Imaging at the NIH. Washington, D.C.: Optica Publishing Group, 1999. http://dx.doi.org/10.1364/ivoi.1999.msi56.
Full textWilson, T., and D. Karadaglić. "Image formation in conventional fluorescence optical microscopes with structured illumination." In In Vivo optical Imaging at the NIH. Washington, D.C.: Optica Publishing Group, 1999. http://dx.doi.org/10.1364/ivoi.1999.msi7.
Full textWebb, Watt W. "Multiphoton Microscopy MPM: Imaging Spectra and Dynamics of Molecular Function Deep in Living Tissues." In In Vivo optical Imaging at the NIH. Washington, D.C.: Optica Publishing Group, 1999. http://dx.doi.org/10.1364/ivoi.1999.msi3.
Full textFaris, Gregory W., Martina Gerken, Mark J. Dyer, and Xingkun Wu. "Optical Matching Techniques and Molecular Upconverting Reporters." In In Vivo optical Imaging at the NIH. Washington, D.C.: Optica Publishing Group, 1999. http://dx.doi.org/10.1364/ivoi.1999.dis172.
Full textReports on the topic "In vivo"
Navarrete, Jesús, Rodrigo Caimanque, Luis Sáenz, Isidora Larrain de Andraca, and Clara Irazábal. Patrimonio vivo: Guía metodológica. Inter-American Development Bank, December 2020. http://dx.doi.org/10.18235/0002908.
Full textNavarrete, Jesús, Rodrigo Caimanque, Luis Sáenz, Isidora Larrain de Andraca, and Clara Irazábal. Patrimonio vivo: Guía metodológica. Inter-American Development Bank, December 2020. http://dx.doi.org/10.18235/0002908.
Full textNavarrete, Jesús, Rodrigo Caimanque, Luis Sáenz, Isidora Larrain de Andraca, and Clara Irazábal. Patrimonio vivo: Documento de enfoque. Inter-American Development Bank, December 2020. http://dx.doi.org/10.18235/0002909.
Full textNavarrete, Jesús, Rodrigo Caimanque, Luis Sáenz, Isidora Larrain de Andraca, and Clara Irazábal. Patrimonio vivo: Documento de enfoque. Inter-American Development Bank, December 2020. http://dx.doi.org/10.18235/0002909.
Full textKruchten, D. A., and D. P. Hickman. Absolute calibration in vivo measurement systems. Office of Scientific and Technical Information (OSTI), February 1991. http://dx.doi.org/10.2172/6063303.
Full textGuelta, Mark A., Steven P. Harvey, and Melissa M. Dixon. Ex Vivo Measurement of Enzyme Stability in Human Plasma: A Potential Screening Method for In Vivo Stability. Fort Belvoir, VA: Defense Technical Information Center, May 2014. http://dx.doi.org/10.21236/ada601155.
Full textSynold, Timothy W. In Vivo Imaging of MDR1A Gene Expression. Fort Belvoir, VA: Defense Technical Information Center, December 2004. http://dx.doi.org/10.21236/ada433034.
Full textNepom, Gerald T. Humanized in vivo Model for Autoimmune Diabetes. Fort Belvoir, VA: Defense Technical Information Center, February 2010. http://dx.doi.org/10.21236/ada523882.
Full textNepom, Gerald T., and John A. Gebe. Humanized in vivo Model for Autoimmune Diabetes. Fort Belvoir, VA: Defense Technical Information Center, February 2009. http://dx.doi.org/10.21236/ada625335.
Full textNepom, Gerald T., and John A. Gebe. Humanized in vivo Model for Autoimmune Diabetes. Fort Belvoir, VA: Defense Technical Information Center, February 2008. http://dx.doi.org/10.21236/ada482199.
Full text